Based in Boston (MA, USA) and France, ImaBiotech offers deep drug investigation services in preclinical to clinical stages, from model validation to patient stratification. The unique proprietary platform combines Spatial Biology and spatial Multi-omics techniques (Mass Spectrometry Imaging, Imaging Mass cytometry, Gene expression) and standard GLP Bioanalytical services for more comprehensive drug efficacy evaluation and more relevant biomarkers identification. To learn more on how ImaBiotech can enhance deliver better preclinical studies, and reduce your time to market, visit www.imabiotech.com
View Top Employees from Imabiotech| Website | http://www.imabiotech.com |
| Revenue | $6 million |
| Employees | 33 (31 on RocketReach) |
| Founded | 2009 |
| Address | 44 Manning Rd Unit 3, Billerica, Massachusetts 01821, US |
| Phone | (978) 362-1825 |
| Technologies |
JavaScript,
HTML,
PHP
+27 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering |
| Web Rank | 11 Million |
| Keywords | Imabiotech, Imabitoech, Imabiotech Spectrometrie De Masse |
| Competitors | Accium BioSciences, BioPharmaSpec, PhenoSwitch Bioscience, Protea Biosciences, Seventh Wave Laboratories LLC |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies |
Looking for a particular Imabiotech employee's phone or email?
Imabiotech Questions
The Imabiotech annual revenue was $6 million in 2023.
Mathieu Gaudin is the Laboratory Director of Imabiotech.
31 people are employed at Imabiotech.
Imabiotech is based in Billerica, Massachusetts.
The NAICS codes for Imabiotech are [541713, 541, 5417, 54171, 54].
The SIC codes for Imabiotech are [873, 87].
Top Imabiotech Employees
-
ViewDavid Calligaris
Project Manager - Cell Therapy at Imabiotech
Boston, Massachusetts, United States31 -
4
-
21
-
45+
-
21
-
2
-
12
Related Companies
